Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina
Clinical trial NCT01861236 · COMPLETED
Trial details
- NCT number
- NCT01861236
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-03-01
- Primary completion
- 2018-09-03
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.